Oaktree Acquisition Corp. III Life Sciences (OACCU) Long-Term Investments (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Long-Term Investments data on file, last reported at $203.4 million in Q1 2026.

• Quarterly Long-Term Investments rose 3.95% year-over-year to $203.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.4 million (up 3.95% YoY) and the FY2025 annual result came in at $201.6 million, up 4.12% from the prior year.
• Long-Term Investments advanced to $203.4 million in Q1 2026, from $201.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $203.4 million in Q1 2026 to a low of $193.6 million in Q4 2024.
• A 3-year average of $198.6 million and a median of $198.7 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments gained 4.12% — and 2026, when it climbed 3.95%.
• Tracing OACCU's Long-Term Investments over 3 years: stood at $193.6 million in 2024, then grew by 4.12% to $201.6 million in 2025, then increased by 0.92% to $203.4 million in 2026.
• The last three Long-Term Investments figures came in at $203.4 million (Q1 2026), $201.6 million (Q4 2025), and $199.8 million (Q3 2025), per Business Quant data.